ARS Pharmaceuticals sets Aug. 13 call for Q2 2026 results, strategy update

President and Chief Executive Officer Donn Casale is scheduled to discuss updated strategic priorities, with a webcast replay available for 30 days after the event.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.